Urologic Oncologist, Associate Professor at Fox Chase Cancer Center/ TUH
Urology
Dr. Rosalia Viterbo, MD
|
|
Give Review
Doctor Rosalia Viterbo, MD works in the field of Urology. He studied medicine at University at Buffalo, School of Medicine and Biomedical Sciences. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Rosalia Viterbo is also published. He has 37 publications published. The lastest publication: "Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based chemotherapy in Muscle-invasive Bladder Cancer.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based chemotherapy in Muscle-invasive Bladder Cancer.
- Development and preliminary testing of PROGRESS: a Web-based education program for prostate Cancer survivors transitioning from active treatment.
- Thinking beyond surgery in the management of renal cell Carcinoma: the risk to die from renal cell Carcinoma and competing risks of death.
- Growth Kinetics and Short Term Outcomes of cT1b and cT2 Renal Masses Under Active Surveillance.
- Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy.
- Renal Pelvic Anatomy Is Associated with Incidence, Grade, and Need for Intervention for Urine Leak Following Partial Nephrectomy.
- Comparison of prostate Cancer diagnosis in patients receiving unrelated urological and non-urological Cancer care.
- Gleason Scoring at a Comprehensive Cancer Center: What's The Difference?
- Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment.
- Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
- Thermal ablation of the small renal mass: Case selection using the R.E.N.A.L.-Nephrometry Score.
- Perioperative Outcomes of Robotic and Open Partial Nephrectomy for Moderately and Highly Complex Renal Lesions.
- Assessing the clinical role of genetic markers of early-onset prostate Cancer among high-risk men enrolled in prostate Cancer early detection.
- Current Status of Robot-Assisted Partial Nephrectomy.
- Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass.
- Small renal masses progressing to metastases under active surveillance: A systematic review and pooled Analysis.
- Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate Cancer.
- Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy.
- Anatomic features of enhancing renal masses predict Malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.
- Routine Adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the Adrenal gland is radiographically normal.
- Prevalence of baseline Chronic kidney disease in patients presenting with solid renal tumors.
- Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised?
- Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up.
- Racial differences in prediction of time to prostate Cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.
- Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder Cancer and is minimally affected by radical cystec...
- Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial Carcinoma: further evidence to support the use of neoadjuvant chemotherapy.
- Psychosocial issue in children and adolescents with multiple sclerosis.
- Robot-assisted partial nephrectomy: a large single-institutional experience.
- Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.
- Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population.
- Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance.
- Residual prostate Cancer after radiotherapy: a study of radical cystoprostatectomy specimens.
- Delayed intervention of sporadic renal masses undergoing active surveillance.
- Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or Adrenal gland.
- Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy afte...
- Incidence and management of dialysis patients with renal calculi.
Schools
Temple University
City Of Hope National Medical Center
SUNYBuffalo
Procedures Preformed
- Adrenalectomy
- Bladder Cancer Surgery
- Bladder Reconstruction
- Bladder Surgery
- View All
Conditions Treated
- Adrenal Cortical Carcinoma
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Oncology
- Urology
Accepted Insurances
- Advantage
- Aetna HMO
- Choice
- Choice Plus POS II
- Choice POS
- Choice PPO
- Commercial HMO
- Elect Choice
- Elect Choice EPO
- Amerihealth HMO
- Amerihealth PPO
- Direct POS
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- EBS-RMSCO
- Geisinger Health Plan
- Choice Care PPO
- Keystone Health Plan East HMO
- Keystone Health Plan East POS
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- QualCare HMO
- QualCare PPO
- Choice Plus POS
- Options PPO
- United Healthcare
- WellPoint
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
City of Hope National Medical Center -
Temple University Hospital -
University at Buffalo, School of Medicine and Biomedical Sciences
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital -
Abington Hospital - Jefferson Health
Drug Facts
| NPI NUMBER | 1912003443 | |
| NPPES Provider LastName | VITERBO | |
| NPPES Provider FirstName | ROSALIA | |
| NPPES Provider ZIPCode | 19111 | |
| NPPES Provider State | PA | |
| Specialty Description | Urology | |
| Total Claim Count | 320.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1912003443 |
| Last Name Of The Provider | VITERBO |
| First Name Of The Provider | ROSALIA |
| View All |
Similar Doctors
|
Dr. Robert Uzzo, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Anton Kapp Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren M. Rittenberg, DO |
|
|
Ryuta Tanimoto
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammed Haseebuddin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdo E. Kabarriti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce B. Garber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin I. Friedlander, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David J. Kraman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lawrence Solish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith N. Van Arsdalen, MD
This Doctor is OpenDoctor Recommended.
|